EXAI Company Profile and Key Details

Q: Who are the executives of EXAI?

Ms. Heather TogwellOperations Mang.Prof. Andrew L. Hopkins DPHIL, FMEDSCI, FRSE FRSCFounder, Chief Executive Officer & Executive DirectorMs. Eileen Jennings-BrownChief Information OfficerMr. Dan IrelandVice President of Legal & Company Sec.Prof. Andrew L. Hopkins DPHIL, FRSE FRSCFounder, Chief Executive Officer & Executive DirectorMr. Ben Ashwell-FryerVice President of Fin.Dr. David Hallett Ph.D.Chief Scientific OfficerMr. Ben R. TaylorChief Financial Officer, Chief Strategy Officer & Executive DirectorMs. Margo MosleyVice President of Facilities & OperationsDr. Michael Krams M.D.Chief Quantitative Medicine OfficerMs. Sara ShermanVice President of Investor RelationsMs. Caroline RowlandChief People OfficerMr. Richard LawChief Bus. OfficerMr. Oliver StohlmannVice President of CommunicationsDr. Garry Pairaudeau Ph.D.AdvisorProf. Charlotte Deane M.B.E., Ph.D.Chief AI Officer

NASDAQ : EXAI

Exscientia

$4.84

N/A-

At Close 4:00 PM

Not Actively Trading

69.85

B+ESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Exscientia plc (EXAI) stock remained unchanged at -, trading at $4.84 on NASDAQ, unchanged from the previous close of -. The stock opened at -, fluctuating between $4.84 and $4.84 in the recent session.

Stock Snapshot

N/A

Prev. Close

633.18M

Market Cap

4.84

Day Low

-3.205298013245033

P/E Ratio

-1.51

EPS (TTM)

-1.15

Cash Flow per Share

N/A

Open

130.82M

Number of Shares

4.84

Day High

64.34%

Free Float in %

2.84

Book Value

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Nov 20, 2024	4.84	4.84	4.84	4.84	0
Nov 19, 2024	4.63	4.85	4.49	4.84	1.51M
Nov 18, 2024	4.74	4.76	4.45	4.69	1.73M
Nov 15, 2024	5.26	5.30	4.69	4.69	2.01M
Nov 14, 2024	5.67	5.79	5.29	5.31	721.78K
Nov 13, 2024	5.89	6.15	5.61	5.61	643.47K
Nov 12, 2024	5.75	6.11	5.65	5.82	879.9K
Nov 11, 2024	5.54	6.49	5.44	5.96	3.19M
Nov 08, 2024	5.25	5.51	5.23	5.44	596.6K
Nov 07, 2024	5.30	5.41	5.15	5.28	423.37K
Nov 06, 2024	5.20	5.36	5.14	5.31	589.4K
Nov 05, 2024	5.01	5.18	4.85	5.17	683.51K
Nov 04, 2024	4.92	5.05	4.80	5.01	512.96K
Nov 01, 2024	4.91	5.04	4.90	4.90	218.81K
Oct 31, 2024	5.09	5.09	4.82	4.86	446.58K
Oct 30, 2024	5.08	5.26	5.08	5.13	340.57K
Oct 29, 2024	5.24	5.24	5.05	5.11	283.06K
Oct 28, 2024	4.92	5.25	4.92	5.23	730.45K
Oct 25, 2024	4.86	5.01	4.80	4.92	340.12K
Oct 24, 2024	4.89	4.89	4.72	4.80	278.93K

Contact Details

Oxford, OX4 4GE

United Kingdom

https://www.recursion.com 441 865 818941

About Company

Exscientia plc is a pioneering pharmatech firm that leverages artificial intelligence (AI) to revolutionize drug discovery and development. The company provides a comprehensive, AI-driven platform that spans the entire drug development lifecycle. This integrated system supports crucial stages, including identifying disease targets, designing potential drug candidates, developing translational models, and optimizing patient selection for clinical trials. A key area of focus for Exscientia is the development of small molecule drug candidates. Through its advanced AI capabilities, the platform not only facilitates the efficient design of novel drug molecules but also employs AI-guided assessments to ensure patients receive the most suitable therapeutic interventions. Established in 2012, Exscientia plc is headquartered in Oxford, United Kingdom.

Stock Peers

ARGX

0.35+0.04%

argenx SE$984.39 REGN

-11.77-1.48%

Regeneron Pharmaceuticals, Inc.$781.49 MDGL

1.37+0.26%

Madrigal Pharmaceuticals, Inc.$534.49 VRTX

0.88+0.17%

Vertex Pharmaceuticals Incorporated$515.44 UTHR

-6.75-1.34%

United Therapeutics Corporation$497.11 KRYS

1.45+0.42%

Krystal Biotech, Inc.$347.00 ONC

4.71+1.38%

BeOne Medicines AG$346.51 PRAX

-3.99-1.18%

Praxis Precision Medicines, Inc.$334.58 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 LGND

-4.78-1.65%

Ligand Pharmaceuticals Incorporated$284.47

Frequently Asked Questions

What is the current Exscientia plc (EXAI) stock price?

Exscientia plc (NASDAQ: EXAI) stock price is $4.84 in the last trading session. During the trading session, EXAI stock reached the peak price of $4.84 while $4.84 was the lowest point it dropped to. The percentage change in EXAI stock occurred in the recent session was N/A while the dollar amount for the price change in EXAI stock was -.

EXAI's industry and sector of operation?

The NASDAQ listed EXAI is part of Biotechnology industry that operates in the broader Healthcare sector. Exscientia plc designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of EXAI?

Ms. Heather Togwell
Operations Mang.
Prof. Andrew L. Hopkins DPHIL, FMEDSCI, FRSE FRSC
Founder, Chief Executive Officer & Executive Director
Ms. Eileen Jennings-Brown
Chief Information Officer
Mr. Dan Ireland
Vice President of Legal & Company Sec.
Prof. Andrew L. Hopkins DPHIL, FRSE FRSC
Founder, Chief Executive Officer & Executive Director
Mr. Ben Ashwell-Fryer
Vice President of Fin.
Dr. David Hallett Ph.D.
Chief Scientific Officer
Mr. Ben R. Taylor
Chief Financial Officer, Chief Strategy Officer & Executive Director
Ms. Margo Mosley
Vice President of Facilities & Operations
Dr. Michael Krams M.D.
Chief Quantitative Medicine Officer
Ms. Sara Sherman
Vice President of Investor Relations
Ms. Caroline Rowland
Chief People Officer
Mr. Richard Law
Chief Bus. Officer
Mr. Oliver Stohlmann
Vice President of Communications
Dr. Garry Pairaudeau Ph.D.
Advisor
Prof. Charlotte Deane M.B.E., Ph.D.
Chief AI Officer

How EXAI did perform over past 52-week?

EXAI's closing price is 0% higher than its 52-week low of $4.84 where as its distance from 52-week high of $4.84 is 0%.

How many employees does EXAI have?

Number of EXAI employees currently stands at 483.

Link for EXAI official website?

Official Website of EXAI is: https://www.recursion.com

How do I contact EXAI?

EXAI could be contacted at phone 441 865 818941 and can also be accessed through its website. EXAI operates from The SchrOedinger Building, Oxford, OX4 4GE, United Kingdom.

How many shares of EXAI are traded daily?

EXAI stock volume for the day was 0 shares. The average number of EXAI shares traded daily for last 3 months was 0.

What is the market cap of EXAI currently?

The market value of EXAI currently stands at $633.18M with its latest stock price at $4.84 and 130.82M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	483
Beta	0.83
Sales or Revenue	$24.96M
5Y Sales Change%	0.63%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	483
Beta	0.83
Sales or Revenue	$24.96M
5Y Sales Change%	0.63%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

EXAI Company Profile and Key Details

Exscientia

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Technical Performance

Earnings & Analyst Outlook

Dividend & Fair Value

Company Overview

Price Forecast & Outlook

Key Takeaways

Valuation Metrics